Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5126]
News [14840]
Articles [105]
Editorials [3]
Conferences [245]
elearning [21]
Positive results in phase II study of copanlisib treating NHL and CLL
Dr George Follows - Cambridge University Hospitals NHS Foundation Trust...
Positive results in phase II study of copanlisib treating NHL and CLL ( Dr George Follows - Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK )
30 Apr 2015
Dual mTOR inhibition effective in reducing tumour load in CLL
Dr Emilio Cosimo - University of Glasgow, Glasgow, UK
Dual mTOR inhibition effective in reducing tumour load in CLL ( Dr Emilio Cosimo - University of Glasgow, Glasgow, UK )
30 Apr 2015
Putting the patient at the centre of cancer-associated thrombosis treatment...
Dr Simon Noble - Cardiff University, Cardiff, UK
Putting the patient at the centre of cancer-associated thrombosis treatment decisions ( Dr Simon Noble - Cardiff University, Cardiff, UK )
30 Apr 2015
Prevention of gynaecological cancers: in memory of Mario Sideri
Dr Susanna Chiocca - European Institute of Oncology, Milan, Italy
Prevention of gynaecological cancers: in memory of Mario Sideri ( Dr Susanna Chiocca - European Institute of Oncology, Milan, Italy )
29 Apr 2015
Inside cancer - public lecture
Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
Inside cancer - public lecture ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
29 Apr 2015
Investigational immunotherapy drug combo safe with early signs of effectiveness...
Dr David Bajor - University of Pennsylvania, Philadelphia, USA
Investigational immunotherapy drug combo safe with early signs of effectiveness in advanced melanoma ( Dr David Bajor - University of Pennsylvania, Philadelphia, USA )
29 Apr 2015
Pembrolizumab showed clinical benefit in malignant pleural mesothelioma
Dr Evan Alley - University of Pennsylvania, Philadelphia, USA
Pembrolizumab showed clinical benefit in malignant pleural mesothelioma ( Dr Evan Alley - University of Pennsylvania, Philadelphia, USA )
29 Apr 2015
New approaches in computational pathology for risk assessment in benign breast...
Dr Andrew Beck - Beth Israel Deaconess Medical Center, Boston, USA
New approaches in computational pathology for risk assessment in benign breast diseases ( Dr Andrew Beck - Beth Israel Deaconess Medical Center, Boston, USA )
29 Apr 2015
Chk1 inhibition combined with standard dose gemcitabine may be safe and...
Dr Jeffrey Infante - Sarah Cannon Research Institute, Nashville, USA
Chk1 inhibition combined with standard dose gemcitabine may be safe and effective ( Dr Jeffrey Infante - Sarah Cannon Research Institute, Nashville, USA )
29 Apr 2015
Developing treatments for indolent non hodgkin lymphoma
Dr Andrew Davies and Dr Paul Fields
Developing treatments for indolent non hodgkin lymphoma ( Dr Andrew Davies and Dr Paul Fields )
29 Apr 2015
Latest trials and outcomes with new CLL treatments
Dr George Follows and Professor Peter Hillmen
Latest trials and outcomes with new CLL treatments ( Dr George Follows and Professor Peter Hillmen )
29 Apr 2015
Updated results on phase III CLL trial shows 90% response rate using ibrutinib
Dr Claire Dearden - Royal Marsden Hospital, London, UK
Updated results on phase III CLL trial shows 90% response rate using ibrutinib ( Dr Claire Dearden - Royal Marsden Hospital, London, UK )
29 Apr 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation